Vir Biotechnology (VIR) Operating Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3,724.00 |
| 10 | Vir Biotechnology | 1.33 Bn | 1.33 Bn | - | -45.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.16 Mn |
| Dec 31, 2025 | 87,195.00 |
| Sep 30, 2025 | -6.25 Mn |
| Jun 30, 2025 | -459,558.00 |
| Mar 31, 2025 | -444,758.00 |
| Dec 31, 2024 | -11,863.00 |
| Sep 30, 2024 | -264,279.00 |
| Jun 30, 2024 | 50,856.00 |
| Mar 31, 2024 | 7,283.00 |
| Dec 31, 2023 | -52,352.00 |
| Sep 30, 2023 | -712,791.00 |
| Jun 30, 2023 | -511,293.00 |
| Mar 31, 2023 | -30,999.00 |
| Dec 31, 2022 | -37,495.00 |
| Sep 30, 2022 | 10,357.00 |
| Jun 30, 2022 | -59,059.00 |
| Mar 31, 2022 | 811,025.00 |
| Dec 31, 2021 | 632,202.00 |
| Sep 30, 2021 | 449,282.00 |
| Jun 30, 2021 | 10,335.00 |
| Mar 31, 2021 | -677,038.00 |
| Dec 31, 2020 | 25,435.00 |
| Sep 30, 2020 | -114,591.00 |
| Jun 30, 2020 | 168,029.00 |
| Mar 31, 2020 | -41,713.00 |
| Dec 31, 2019 | -564,882.00 |
| Sep 30, 2019 | -220,793.00 |